H. Westenberg

发表

Advances in the neurobiology of anxiety disorders

H. Westenberg, J. A. Boer, D. Murphy, 1996 .

Dysfunctional Reward Circuitry in Obsessive-Compulsive Disorder

H. Westenberg, M. Vink, D. Veltman, 2011, Biological Psychiatry.

Genome-wide association study of obsessive-compulsive disorder

Y Wang, Dan J Stein, D V Conti, 2013, Molecular Psychiatry.

Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture

Benjamin D. Greenberg, Ying Wang, Naomi R. Wray, 2013, PLoS genetics.

Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder.

H. Westenberg, D. Denys, M. Figee, 2010, Archives of general psychiatry.

Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder.

H. Westenberg, W. Nolen, D. Denys, 2011, Journal of affective disorders.

Neural correlates of associative learning and memory in veterans with posttraumatic stress disorder.

H. Westenberg, M. Ruf, E. Geuze, 2008, Journal of psychiatric research.

Wireless implantable micro-stimulation device for high frequency bilateral deep brain stimulation in freely moving mice

H. Westenberg, M. Kas, G. Plasse, 2012, Journal of Neuroscience Methods.

Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder

R. Boellaard, H. Westenberg, A. Lammertsma, 2008, Molecular Psychiatry.

Advances in the neurobiology of schizophrenia

H. Westenberg, J. A. Boer, H. M. Praag, 1995 .

Disgust affects TNF-α, IL-6 and noradrenalin levels in patients with obsessive–compulsive disorder

H. Westenberg, D. Denys, C. Heijnen, 2010, Psychoneuroendocrinology.

Stimulation of the pituitary-adrenal system with graded doses of CRH and low dose vasopressin infusion in depressed patients and healthy subjects: a pilot study

H. Westenberg, J. M. Ree, C. Wied, 1993, European Neuropsychopharmacology.

The clinical significance of atypical antipsychotics

H. Westenberg, J. A. Boer, J. Louwerens, 1991, Acta Neuropsychiatrica.

Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review

H. Westenberg, E. Geuze, E. Vermetten, 2006, International clinical psychopharmacology.

Genome-wide association study of obsessive-compulsive disorder

Dan J Stein, R. Delorme, M. Leboyer, 2013, Molecular Psychiatry.

Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder

H. Westenberg, E. Geuze, E. Vermetten, 2007, Molecular Psychiatry.

Deep Brain Stimulation Reveals a Dissociation of Consummatory and Motivated Behaviour in the Medial and Lateral Nucleus Accumbens Shell of the Rat

H. Westenberg, L. Vanderschuren, G. van der Plasse, 2012, PloS one.

Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety.

H. Westenberg, D. Nutt, J. Davidson, 1998, The Journal of clinical psychiatry.

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

H. Westenberg, J. A. Boer, M. Traub, 1994, Psychopharmacology.

The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder

H. Westenberg, J. A. Boer, R. Kahn, 1996, European Neuropsychopharmacology.

Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia.

H. Westenberg, R. Kahn, C. Gispen-de Wied, 2002, Journal of clinical psychopharmacology.

A double‐blind comparative study of remoxipride and haloperidol in acute schizophrenia.

W. Verhoeven, H. Westenberg, J. A. Boer, 1990, Acta psychiatrica Scandinavica. Supplementum.

Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients.

H. Westenberg, D. Denys, N. Vulink, 2009, The Journal of clinical psychiatry.

Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats

H. Westenberg, A. Klompmakers, F. Bosker, 1995, Psychopharmacology.

Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder

R. Boellaard, H. Westenberg, D. Veltman, 2013, European Neuropsychopharmacology.

Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.

W. Verhoeven, H. Westenberg, J. A. Boer, 1987, International clinical psychopharmacology.

A decade of biological psychiatric research on OCD (I): introduction and treatment-studies

H. Westenberg, J. A. Boer, A. S. D. Leeuw, 1993, Acta Neuropsychiatrica.

Noradrenaline concentrations and electrocardiographic abnormalities after aneurysmal subarachnoid haemorrhage.

H. Westenberg, J. van Gijn, P. Brouwers, 1995, Journal of neurology, neurosurgery, and psychiatry.

Endocrine and cardiovascular responses to a series of graded physical and psychological stress stimuli in healthy volunteers

Jan M. van Ree, H. Westenberg, J. M. Ree, 1995, European Neuropsychopharmacology.

Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder

H. Westenberg, J. D. den Boer, H. van Megen, 1998, Psychopharmacology.

L-5-hydroxytryptophan in the treatment of anxiety disorders.

H. Westenberg, R. Kahn, 1985, Journal of affective disorders.

Serotonin function in panic disorder: effect of 1–5-hydroxytryptophan in patients and controls

H. Westenberg, J. A. Boer, 2004, Psychopharmacology.

Serotonergic function and late luteal phase dysphoric disorder

H. Westenberg, A. Veeninga, 2005, Psychopharmacology.

Immunoglobulin production in vitro in major depression: A pilot study on the modulating action of endogenous cortisol

H. Westenberg, J. M. Ree, C. Heijnen, 1995, Biological Psychiatry.

Inhibition of the pituitary-adrenal axis with dexamethasone and cortisol in depressed patients and healthy subjects: A dose-response study

W. Verhoeven, H. Westenberg, J. M. Ree, 1993, Psychoneuroendocrinology.

Stimulation of the pituitary-adrenal axis with a low dose [Arg8]-vasopressin in depressed patients and healthy subjects

H. Westenberg, J. M. Ree, H. Koppeschaar, 1992, European Neuropsychopharmacology.

The dexamethasone and cortisol suppression test in depression: β-endorphin as a useful marker

H. Westenberg, J. M. Ree, J. Thijssen, 1987, Psychoneuroendocrinology.

Psychopharmacology of anxiety disorders: on the role of serotonin in the treatment of anxiety states and phobic disorders.

H. Westenberg, J. D. den Boer, R. Kahn, 1987, Psychopharmacology bulletin.

Zimeldine treatment of obsessive‐compulsive disorder

H. Westenberg, J. Jolles, R. Kahn, 1984, Acta psychiatrica Scandinavica.

Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder

H. Westenberg, E. Geuze, E. Vermetten, 2007, Psychoneuroendocrinology.

Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors

H. Westenberg, J. Zohar, 2000, Acta psychiatrica Scandinavica. Supplementum.

Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.

W. Verhoeven, H. Westenberg, C. Gispen-de Wied, 1987, International clinical psychopharmacology.

Mirtazapine in social anxiety disorder: a pilot study

H. Westenberg, I. V. van Vliet, J. F. van Veen, 2002, International clinical psychopharmacology.

Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder.

H. Westenberg, E. Geuze, G. Stalla, 2008, Progress in brain research.

Paroxetine augmentation in patients with generalised social anxiety disorder, non‐responsive to mirtazapine or placebo

H. Westenberg, K. Schruers, H. van Megen, 2011, Human psychopharmacology.

Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study

H. Westenberg, D. Denys, H. van Megen, 2010, International clinical psychopharmacology.

Perception of facial expressions in obsessive-compulsive disorder: A dimensional approach

H. Westenberg, R. Kessels, E. D. de Haan, 2008, European Psychiatry.

Food cues and ghrelin recruit the same neuronal circuitry

H. Westenberg, A. B. Mulder, M. Luijendijk, 2013, International Journal of Obesity.

A decade of biological-psychiatric research in OCD (II): challenge-studies and neuroanatomical substrate

H. Westenberg, J. A. Boer, A. S. D. Leeuw, 1993, Acta Neuropsychiatrica.

Neurobiology of anxiety disorders: Focus on neuroimaging

H. Westenberg, 2000, European Neuropsychopharmacology.

Clinical and Biochemical Effects of Selective Serotonin-Uptake Inhibitors in Anxiety Disorders

H. Westenberg, J. A. Boer, 1988 .

Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients

H. Westenberg, J. A. Boer, H. Megen, 1996, Biological Psychiatry.

On the significance of cholecystokinin receptors in panic disorder

H. Westenberg, J. A. Boer, H. Megen, 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Placebo-controlled studies in depression: necessary, ethical and feasible

H. Möller, H. Westenberg, S. Kasper, 2003, European Archives of Psychiatry and Clinical Neuroscience.

Decreased TNF-alpha and NK activity in obsessive-compulsive disorder.

H. Westenberg, D. Denys, A. Kavelaars, 2004, Psychoneuroendocrinology.

Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740

H. Westenberg, V. Bergink, 2005, International clinical psychopharmacology.

[Body dysmorphic disorder in 3-8% of patients in outpatient dermatology and plastic surgery clinics].

M. Kon, H. Westenberg, D. Denys, 2006, Nederlands tijdschrift voor geneeskunde.

P.1.b.014 Deep brain stimulation of the nucleus accumbens for therapy-refractory obsessive-compulsive disorder

H. Westenberg, D. Denys, M. Figee, 2010, European Neuropsychopharmacology.

Do panic attacks reflect an abnormality in serotonin receptor subtypes?

H. Westenberg, J. D. den Boer, 1991 .

Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.

H. Westenberg, E. Geuze, E. Vermetten, 2006, Journal of psychiatric research.

Pharmacotherapeutic Treatment of Nightmares and Insomnia in Posttraumatic Stress Disorder

H. Westenberg, E. Geuze, E. Vermetten, 2006, Annals of the New York Academy of Sciences.

Biological Aspects of Panic Anxiety

W. Verhoeven, H. Westenberg, J. A. Boer, 1990 .

Critical notes on the locus coeruleus hypothesis of panic disorder

H. Westenberg, J. D. den Boer, 1993, Acta Neuropsychiatrica.

Decreased nocturnal growth hormone secretion and sleep fragmentation in combat-related posttraumatic stress disorder; potential predictors of impaired memory consolidation

Eric Vermetten, H. Westenberg, E. Vermetten, 2011, Psychoneuroendocrinology.

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

H. Westenberg, J. A. Boer, I. V. Vliet, 1994, Psychopharmacology.

Cholecystokinin in anxiety

H. Westenberg, J. A. Boer, R. Kahn, 1996, European Neuropsychopharmacology.

EVIDENCE OF ENHANCED SENSITIVITY FOR PENTAGASTRIN IN PANIC DISORDER PATIENTS

H. Westenberg, J. D. den Boer, H. van Megen, 1993, Acta Neuropsychiatrica.

A comparative study on the antipsychotic properties of desenkephalin‐γ‐endorphin and ceruletide in schizophrenic patients

W. Verhoeven, H. Westenberg, J. M. Ree, 1986, Acta psychiatrica Scandinavica.

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.

H. Westenberg, J. D. den Boer, H. van Megen, 1994, Archives of general psychiatry.

Neuropeptides and anxiety disorders

H. Westenberg, J. D. den Boer, H. van Megen, 1992, Acta Neuropsychiatrica.

Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder

H. Westenberg, J. A. Boer, 1990, Psychiatry Research.

Behavioral biochemical and neuroendocrine concomitants of lactate-induced panic anxiety

H. Westenberg, J. A. Boer, A. Klompmakers, 1989, Biological Psychiatry.

L‐365,260, A CCKB ANTAGONIST, BLOCKS CCK‐4‐PANIC IN PANIC DISORDER

H. Westenberg, J. D. den Boer, H. van Megen, 1992 .

Neuroleptic malignant syndrome: Successful treatment with bromocriptine

W. Verhoeven, H. Westenberg, A. Elderson, 1985, Biological Psychiatry.

(Des-tyrosine1)-gamma-endorphin in schizophrenia: Clinical, biochemical, and hormonal aspects

W. Verhoeven, H. Westenberg, J. M. Ree, 1981, Psychiatry Research.

The Effect of Olanzapine Treatment on Monoamine Metabolite Concentrations in the Cerebrospinal Fluid of Schizophrenic Patients

H. Westenberg, R. Kahn, F. Scheepers, 2001, Neuropsychopharmacology.

Autonomic and Neuroendocrine Responses to a Psychosocial Stressor in Adults with Autistic Spectrum Disorder

H. Engeland, H. Westenberg, L. Jansen, 2006, Journal of autism and developmental disorders.

The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress.

H. Westenberg, B. Olivier, D. Fekkes, 2000, The American journal of clinical nutrition.

Recent advances in the psychopharmacology of social phobia

H. Westenberg, J. A. Boer, I. V. Vliet, 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Recent developments in the psychopharmacology of social phobia

H. Westenberg, J. A. Boer, I. V. Vliet, 1993, Acta Neuropsychiatrica.

MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine

H. Westenberg, J. A. Boer, I. V. Vliet, 1993, Psychopharmacology.

Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks

H. Westenberg, J. D. den Boer, H. van Megen, 1997, Psychopharmacology.

Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry.

H. Westenberg, D. Stein, M. Liebowitz, 2002, The Journal of clinical psychiatry.

Postsynaptic serotonergic activity in depressive patients: Evaluation of the neuroendocrine strategy

H. Westenberg, J. Thijssen, H. Praag, 1982, Psychiatry Research.

Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade

H. Westenberg, B. Olivier, A. Klompmakers, 2003, Psychopharmacology.

An evaluation of the effect of NAS-181, a new selective 5-HT1B receptor antagonist, on extracellular 5-HT levels in rat frontal cortex

H. Westenberg, B. Olivier, A. Klompmakers, 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT1B autoreceptors: a microdialysis study in knockout mice

H. Westenberg, B. Olivier, L. de Groote, 2002, Psychopharmacology.

Pedophilia is accompanied by increased plasma concentrations of catecholamines, in particular epinephrine

H. Westenberg, H. Neels, M. Maes, 2001, Psychiatry Research.

Prazosin addition to fluvoxamine: A preclinical study and open clinical trial in OCD

H. Westenberg, D. Denys, M. Figee, 2016, European Neuropsychopharmacology.

Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine

H. Westenberg, J. A. Boer, T. Klaassen, 1998, Psychiatry Research.

Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients

H. Westenberg, J. A. Boer, W. Brink, 2000, Biological Psychiatry.

Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe.

H. Westenberg, A. Klompmakers, F. Bosker, 1997, European journal of pharmacology.

Pharmacokinetics of clomipramine in depressive patients

H. Westenberg, H. Praag, R. D. Zeeuw, 1981, Psychiatry Research.

Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.

S. E. Stewart, C. Sabatti, N. Freimer, 2015, The American journal of psychiatry.

Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive–compulsive disorder in males

H. Westenberg, D. Denys, D. Deforce, 2006, European Neuropsychopharmacology.

Clinical, biochemical, and hormonal aspects of treatment with des-tyr1-gamma-endorphin in schizophrenia

W. Verhoeven, H. Westenberg, R. Kahn, 1984, Psychiatry Research.

Increasing Dopaminergic Activity: Effects of L-Dopa and Bromocriptine on Human Sensory Gating

H. Westenberg, R. Kahn, C. Kemner, 2004, Journal of psychopharmacology.

Sensory gating and sensorimotor gating in medication-free obsessive-compulsive disorder patients

H. Westenberg, C. Kemner, B. Oranje, 2010, International clinical psychopharmacology.

A Double Blind Comparison of Venlafaxine and Paroxetine in Obsessive-Compulsive Disorder

H. Westenberg, D. Denys, H. van Megen, 2003, Journal of clinical psychopharmacology.

Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder.

H. Westenberg, E. Geuze, E. Vermetten, 2008, Journal of psychiatric research.

Decreased TNF-α and NK activity in obsessive-compulsive disorder

H. Westenberg, D. Denys, A. Kavelaars, 2004, Psychoneuroendocrinology.

Oxytocin in obsessive compulsive disorder

H. Westenberg, J. A. Boer, 1992, Peptides.

IMPACT OF IMPAIRED SLEEP ON THE DEVELOPMENT OF PTSD SYMPTOMS IN COMBAT VETERANS: A PROSPECTIVE LONGITUDINAL COHORT STUDY

H. Westenberg, E. Vermetten, M. van Zuiden, 2013, Depression and anxiety.

Attention and cognition in patients with obsessive–compulsive disorder

H. Westenberg, D. Denys, M. Sitskoorn, 2007, Psychiatry and clinical neurosciences.

Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response.

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1996, Journal of affective disorders.

CONCEPTS OF ANXIETY: A HISTORICAL REFLECTION ON ANXIETY AND RELATED DISORDERS Published as: Glas, G. (1996), Concepts of anxiety: a historical reflection on anxiety and related disorders. In:

H. Westenberg, J. A. Boer, D. L. Murphy, 2010 .

Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients

H. Westenberg, R. Kahn, J. M. Ree, 1996, Biological Psychiatry.

Effects of quetiapine on cognitive functioning in obsessive–compulsive disorder

H. Westenberg, D. Denys, F. de Geus, 2007, International clinical psychopharmacology.

Anhedonia, suicide ideation and dexamethasone nonsuppression in depressed patients.

W. Verhoeven, H. Westenberg, F. Zwart, 1990, Journal of psychiatric research.

Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.

H. Westenberg, D. Denys, D. Deforce, 2007, The Journal of clinical psychiatry.

Thinner prefrontal cortex in veterans with posttraumatic stress disorder

Rainer Goebel, Elbert Geuze, Herman G.M. Westenberg, 2008, NeuroImage.

Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine

H. Westenberg, N. Ramsey, R. Mandl, 2005, Psychiatry Research: Neuroimaging.

Glutamate and anxiety

H. Westenberg, V. Bergink, Harold J. G. M van Megen and, 2004, European Neuropsychopharmacology.

Serotonergic functioning in children with oppositional defiant disorder: a sumatriptan challenge study

H. Engeland, H. Westenberg, H. Koppeschaar, 2002, Biological Psychiatry.

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

H. Westenberg, J. A. Boer, 2005, Psychopharmacology.

Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive–compulsive disorder: possible mechanisms and implications for clinical care

H. Westenberg, D. Denys, H. van Megen, 2003, Journal of psychopharmacology.

Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia

H. Westenberg, J. A. Boer, W. Fleischhacker, 1995, Psychopharmacology.

Neurobiology of Obsessive-Compulsive Disorder: Serotonin and Beyond

H. Westenberg, N. Fineberg, D. Denys, 2007, CNS Spectrums.

Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats.

H. Westenberg, C. Kruse, H. Bouwmeester, 2007, The international journal of neuropsychopharmacology.

Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis.

H. Westenberg, R. Kahn, J. Lijmer, 2012, Schizophrenia bulletin.

Saccadic abnormalities in psychotropic-naive obsessive–compulsive disorder without co-morbidity

H. Westenberg, N. Ramsey, M. Raemaekers, 2006, Psychological Medicine.

Neuroendocrine and immune responses to a cognitive stress challenge in veterans with and without PTSD

H. Westenberg, E. Geuze, E. Vermetten, 2012, European journal of psychotraumatology.

Obstructive sleep apnea in combat-related posttraumatic stress disorder: a controlled polysomnography study

H. Westenberg, E. Vermetten, J. Arends, 2011, European journal of psychotraumatology.

Attachment representations in Dutch veterans with and without deployment-related PTSD

H. Westenberg, M. Bakermans-Kranenburg, Marinus H. van IJzendoorn, 2009, Attachment & human development.

Sexual pleasure in women with obsessive-compulsive disorder?

H. Westenberg, D. Denys, N. Vulink, 2006, Journal of affective disorders.

Plasma monoamine metabolites and aggression: two studies of normal and oppositional defiant disorder children

H. Engeland, H. Westenberg, P. Cohen-Kettenis, 1999, European Neuropsychopharmacology.

Recent Advances in Understanding and Treating Social Anxiety Disorder

H. Westenberg, 2009, CNS Spectrums.

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor

H. Westenberg, J. A. Boer, I. V. Vliet, 1992, European Neuropsychopharmacology.

Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder

H. Westenberg, J. A. Boer, I. V. Vliet, 1996, Psychopharmacology.

The effects of A 5-HT1A receptor agonist and antagonist on the 5-hydroxytryptamine release in the central nucleus of the amygdala: a microdialysis study with flesinoxan and WAY 100635

H. Westenberg, A. Klompmakers, D. Vrinten, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

Lipopolysaccharide-induced cytokine production in obsessive–compulsive disorder and generalized social anxiety disorder

H. Westenberg, D. Denys, N. Vulink, 2010, Psychiatry Research.

Sympathetic activity and hypothalamo-pituitary–adrenal axis activity during sleep in post-traumatic stress disorder: A study assessing polysomnography with simultaneous blood sampling

H. Westenberg, R. Kahn, P. Cluitmans, 2013, Psychoneuroendocrinology.

Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder

H. Westenberg, E. Geuze, E. Vermetten, 2008, Psychoneuroendocrinology.

Precuneal activity during encoding in veterans with posttraumatic stress disorder.

Eric Vermetten, Elbert Geuze, H. Westenberg, 2008, Progress in brain research.

Altered pain processing in veterans with posttraumatic stress disorder.

Eric Vermetten, Christian Schmahl, Martin Bohus, 2007, Archives of general psychiatry.

Reduced sensitivity in the recognition of anger and disgust in social anxiety disorder

H. Westenberg, R. Kessels, E. D. de Haan, 2006, Cognitive neuropsychiatry.

Female hormones affect symptom severity in obsessive–compulsive disorder

H. Westenberg, D. Denys, N. Vulink, 2006, International clinical psychopharmacology.

Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?

H. Westenberg, 1996, Journal of affective disorders.

Fluvoxamine in the treatment of menstrually related mood disorders

H. Westenberg, A. Veeninga, Joseph T. N. Weusten, 2005, Psychopharmacology.

Overview of panic and social anxiety disorders.

H. Westenberg, M. Liebowitz, 2004, The Journal of clinical psychiatry.

Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.

H. Westenberg, D. Denys, H. van Megen, 2002, The Journal of clinical psychiatry.

The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence.

H. Westenberg, D. Denys, J. Zohar, 2004, The Journal of clinical psychiatry.

The effects of selective serotonin reuptake inhibitors on extracellular 5-HT in the hippocampus of 5-HT 1 B receptor knockout mice

H. Westenberg, B. Olivier, L. de Groote, 2002 .

Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.

H. Westenberg, R. Gooskens, J. Willemse, 1984, Neuropediatrics.

Increased Serotonin and Dopamine Transporter Binding in Psychotropic Medication–Naïve Patients with Generalized Social Anxiety Disorder Shown by 123I-β-(4-Iodophenyl)-Tropane SPECT

H. Westenberg, P. V. van Rijk, H. Stevens, 2008, Journal of Nuclear Medicine.

Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls

H. Westenberg, J. A. Boer, K. L. Pian, 1997, Biological Psychiatry.

A score for predicting response to pharmacotherapy in obsessive–compulsive disorder

H. Westenberg, D. Denys, H. van Megen, 2003, International clinical psychopharmacology.

Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude.

Bob Oranje, Chantal Kemner, Christine C Gispen-de Wied, 2009, The international journal of neuropsychopharmacology.

No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention

H. Westenberg, R. Kahn, C. Kemner, 2006, Journal of psychopharmacology.

A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1996, Journal of clinical psychopharmacology.

Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder

H. Westenberg, D. Denys, F. D. Geus, 2004, Psychiatry Research.

H. Engeland, H. Westenberg, J. Kenemans, 2006, European Psychiatry.

Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: An in vivo microdialysis study

H. Westenberg, B. Olivier, M. Breuer, 2005, Biological Psychiatry.

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study.

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1997, The Journal of clinical psychiatry.

Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine

H. Westenberg, D. Denys, A. Klompmakers, 2004, Psychopharmacology.

d-Cycloserine Addition to Exposure Sessions in the Treatment of Patients With Obsessive-Compulsive Disorder

H. Westenberg, H. van Megen, R. Kahn, 2017, European Psychiatry.

A Double-Blind Placebo-Controlled Study of Controlled Release Fluvoxamine for the Treatment of Generalized Social Anxiety Disorder

H. Westenberg, D. Stein, Hai-chen Yang, 2003, Journal of clinical psychopharmacology.

Effects of methylphenidate, desipramine, and l-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder

H. Engeland, H. Westenberg, J. Kenemans, 2003, Behavioural Brain Research.

Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder.

H. Westenberg, D. Denys, D. Deforce, 2006, Journal of affective disorders.

Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder

H. Westenberg, D. Denys, J. Janssen, 2004, Biological Psychiatry.

Long-Term Behavioral Changes After Cessation of Chronic Antidepressant Treatment in Olfactory Bulbectomized Rats

H. Westenberg, R. Oosting, B. Olivier, 2007, Biological Psychiatry.

The effect of stress on the dexamethasone suppression test

H. Westenberg, H. Praag, D. L. Ceulemans, 1985, Psychiatry Research.

The bovine protein a-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids , and in vulnerable subjects raises brain serotonin activity , reduces cortisol concentration , and improves mood under stress 1 – 3 C

H. Westenberg, J. Gugten, B. Olivier, 2015 .

Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorder.

H. Westenberg, D. Denys, H. van Megen, 2004, Journal of affective disorders.

Symptom Dimensions in Obsessive-Compulsive Disorder: Factor Analysis on a Clinician-Rated Scale and a Self-Report Measure

H. Westenberg, D. Denys, H. van Megen, 2004, Psychopathology.

Remoxipride in Adolescents with Tourette's Syndrome : An Open Pilot Study

H. Westenberg, J. Buitelaar, P. Cohen-Kettenis, 1995 .

Effect of a pharmacological intervention on quality of life in patients with obsessive–compulsive disorder

H. Westenberg, D. Denys, H. van Megen, 2003, International clinical psychopharmacology.

Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice.

H. Westenberg, B. Olivier, L. de Groote, 2003, European journal of pharmacology.

Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder

H. Westenberg, J. A. Boer, I. V. Vliet, 1996, European Neuropsychopharmacology.

Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.

H. Westenberg, A. D. de Leeuw, 2008, Journal of psychiatric research.

Reply to Joseph et al.

H. Westenberg, H. Praag, 1984, Psychiatry Research.

Letter Hormone response to 5-HTP: a reply

H. Westenberg, J. Thijssen, H. Praag, 1984, Psychiatry Research.

Catechol-O-methyltranferase gene expression is associated with response to citalopram in obsessive-compulsive disorder

H. Westenberg, D. Denys, D. Deforce, 2012, International journal of psychiatry in clinical practice.

Remoxipride in schizophrenia

W. Verhoeven, H. Westenberg, J. A. Boer, 1986, Acta psychiatrica Scandinavica.

Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients

W. Verhoeven, H. Westenberg, J. A. Boer, 2005, Psychopharmacology.

Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive–compulsive disorder and controls

H. Westenberg, J. A. Boer, P. Rijk, 1998, Biological Psychiatry.

Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.

H. Westenberg, D. Denys, H. van Megen, 2005, The Journal of clinical psychiatry.

Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.

H. Westenberg, H. Meltzer, H. Neels, 1997, Journal of clinical psychopharmacology.

MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients

H. Westenberg, J. A. Boer, I. V. Vliet, 1996, Psychopharmacology.

MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients A preliminary report

H. Westenberg, J. A. Boer, I. V. van Vliet, 1996, Psychopharmacology.

The nature of social anxiety disorder.

H. Westenberg, 1998, The Journal of clinical psychiatry.

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.

H. Westenberg, D. Stein, Hai-chen Yang, 2003, The international journal of neuropsychopharmacology.

Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study.

H. Westenberg, H. van Megen, S. Schutters, 2005, The Journal of clinical psychiatry.

Facing the challenge of social anxiety disorder

H. Westenberg, 1999, European Neuropsychopharmacology.

Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study.

H. Westenberg, D. Denys, N. Vulink, 2005, The Journal of clinical psychiatry.

A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.

H. Westenberg, D. Denys, H. van Megen, 2004, The Journal of clinical psychiatry.

Pharmacological treatment of social phobia; recent developments

H. Westenberg, J. A. Boer, I. V. Vliet, 1993, European Neuropsychopharmacology.

Kinetics of l-5-hydroxytryptophan in healthy subjects

H. Westenberg, H. Praag, Ton W. Gerritsen, 1982, Psychiatry Research.

Serotonin-influencing drugs in the treatment of panic disorder.

H. Westenberg, J. D. den Boer, 1989, Psychopathology.

Signaling pathways involved in Ca2+- and Pb2+-induced vesicular catecholamine release from rat PC12 cells

H. Westenberg, R. Westerink, H. Vijverberg, 2002, Brain Research.

Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex

Nick F. Ramsey, René S. Kahn, Nic J. A. van der Wee, 2003, NeuroImage.

Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive–compulsive disorder: a meta-analysis of randomized controlled treatment trials

Dan J Stein, H. Westenberg, S. Seedat, 2006, International clinical psychopharmacology.

A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.

H. Westenberg, D. Denys, H. van Megen, 2004, The Journal of clinical psychiatry.

The adequacy of pharmacotherapy in outpatients with obsessive–compulsive disorder

H. Westenberg, D. Denys, H. van Megen, 2002, International clinical psychopharmacology.

Pentagastrin has panic-inducing properties in obsessive compulsive disorder

H. Westenberg, J. A. Boer, A. S. D. Leeuw, 1996, Psychopharmacology.

Significance of CCK-B receptors in the neurobiology of panic disorder

H. Westenberg, J. A. Boer, H. V. Megen, 1994, European Neuropsychopharmacology.

Treatment of panic disorder: Algorithms for pharmacotherapy.

H. Westenberg, J. Lépine, A. Pelissolo, 1997, International journal of psychiatry in clinical practice.

Behavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats

H. Westenberg, M. Kas, R. de Haas, 2011, Journal of psychopharmacology.

Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1995, International clinical psychopharmacology.

Biological dissection of anxiety disorders

H. Westenberg, J. A. Boer, A. S. D. Leeuw, 1995 .

Neuroimaging of Pain Perception in Dutch Veterans With and Without Posttraumatic Stress Disorder: Preliminary Results

H. Westenberg, C. Schmahl, M. Bohus, 2006, Annals of the New York Academy of Sciences.

Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysis

H. Westenberg, H. Oppelaar, M. Kas, 2012, European Neuropsychopharmacology.

5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: Modulation by pindolol

H. Westenberg, A. Klompmakers, F. Bosker, 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Assessment of DSM-IV personality disorders in obsessive-compulsive disorder: comparison of clinical diagnosis, self-report questionnaire, and semi-structured interview.

H. Westenberg, D. Denys, H. van Megen, 2003, Journal of personality disorders.

Panic Disorder—a Condition for Life? Treatment Issues

H. Westenberg, 1997 .

Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats

H. Westenberg, B. Olivier, L. Broersen, 2004, Psychopharmacology.

Serotonergic compounds in panic disorder, obsessive‐compulsive disorder and anxious depression: A concise review

H. Westenberg, J. D. den Boer, H. G. M. Westenberg, 1995, Human psychopharmacology.

Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1995, Journal of affective disorders.

New Findings in the Treatment of Panic Disorder

H. Westenberg, J. A. Boer, 1993, Pharmacopsychiatry.

The MSH/ACTH analog ORG 2766 in anxiety disorders

H. Westenberg, J. A. Boer, H. Vries, 1992, Peptides.

Remoxipride, a novel atypical neuroleptic, in the treatment of schizophrenia.

W. Verhoeven, H. Westenberg, J. D. den Boer, 1987, Psychopharmacology bulletin.

Characteristics of patients with social phobia and their treatment in specialized clinics for anxiety disorders in the Netherlands.

H. Westenberg, I. V. van Vliet, J. Couvée, 2001, Journal of affective disorders.

IMPACT OF IMPAIRED SLEEP ON THE DEVELOPMENT OF PTSD SYMPTOMS IN COMBAT VETERANS: A PROSPECTIVE LONGITUDINAL COHORT STUDY

H. Westenberg, E. Vermetten, M. van Zuiden, 2013, Depression and anxiety.

Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms

H. Westenberg, D. Denys, D. Deforce, 2009, International journal of psychiatry in clinical practice.

Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls

H. Westenberg, N. V. D. Wee, H. V. Megen, 2004, European Neuropsychopharmacology.

Decreased nocturnal growth hormone secretion and sleep fragmentation in combat-related posttraumatic stress disorder; potential predictors of impaired memory consolidation

H. Westenberg, E. Vermetten, E. Lentjes, 2011, Psychoneuroendocrinology.

Lower Baseline Plasma Cortisol and Prolactin together with Increased Body Temperature and Higher mCPP-Induced Cortisol Responses in Men with Pedophilia

H. Westenberg, M. Maes, P. Cosyns, 2001, Neuropsychopharmacology.

Short communication Dose-related effect of methylphenidate on stopping and changing in children with attention-deficit/hyperactivity disorder

H. Engeland, H. Westenberg, J. Kenemans, 2006 .

Increased Serotonin and Dopamine Transporter Binding in Psychotropic Medication–Naïve Patients with Generalized Social Anxiety Disorder Shown by 123I-β-(4-Iodophenyl)-Tropane SPECT

H. Westenberg, P. V. van Rijk, H. Stevens, 2008, Journal of Nuclear Medicine.

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.

H. Westenberg, J. D. den Boer, 1988, International clinical psychopharmacology.

The embarrassed brain : towards a neurobiology of generalized socal anxiety disorder

H. Westenberg, J. V. Veen, I. M. V. Vliet, 2010 .

Imaging trauma in vivo: GABAA benzodiazepine receptor binding

H. Westenberg, E. Geuze, E. Vermetten, 2008, Molecular Psychiatry.